Alps Advisors Inc Celldex Therapeutics, Inc. Transaction History

Alps Advisors Inc

  • $17.2 Billion
  • Q2 2025

A detailed history of Alps Advisors Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 35,812 shares of CLDX stock, worth $852,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,812
Previous 49,938 28.29%
Holding current value
$852,325
Previous $906,000 19.65%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$15.13 - $21.65 $213,726 - $305,827
-14,126 Reduced 28.29%
35,812 $728,000
Q1 2025

Apr 30, 2025
SELL
$18.15 - $27.6 $67,372 - $102,451
-3,712 Reduced 6.92%
49,938 $906,000
Q4 2024

Feb 13, 2025
BUY
$23.31 - $32.4 $69,766 - $96,973
2,993 Added 5.91%
53,650 $1.36 Million
Q3 2024

Nov 12, 2024
SELL
$32.06 - $44.56 $23,788 - $33,063
-742 Reduced 1.44%
50,657 $1.72 Million
Q2 2024

Aug 13, 2024
BUY
$32.76 - $42.56 $195,216 - $253,615
5,959 Added 13.11%
51,399 $1.9 Million
Q1 2024

May 14, 2024
BUY
$35.22 - $51.88 $274,539 - $404,404
7,795 Added 20.71%
45,440 $1.91 Million
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $63,240 - $113,698
2,797 Added 8.03%
37,645 $1.49 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $2,875 - $4,232
113 Added 0.33%
34,848 $959,000
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $109,952 - $138,956
3,630 Added 11.67%
34,735 $1.18 Million
Q1 2023

May 10, 2023
SELL
$34.78 - $47.43 $29,354 - $40,030
-844 Reduced 2.64%
31,105 $1.12 Million
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $177,486 - $289,932
6,389 Added 25.0%
31,949 $1.42 Million
Q3 2022

Nov 14, 2022
SELL
$22.7 - $37.57 $49,486 - $81,902
-2,180 Reduced 7.86%
25,560 $718,000
Q2 2022

Aug 11, 2022
BUY
$20.5 - $37.33 $568,670 - $1.04 Million
27,740 New
27,740 $748,000
Q2 2021

Aug 11, 2021
SELL
$20.71 - $35.37 $1.48 Million - $2.53 Million
-71,581 Closed
0 $0
Q1 2021

May 07, 2021
BUY
$16.19 - $29.91 $13,939 - $25,752
861 Added 1.22%
71,581 $1.48 Million
Q4 2020

Feb 03, 2021
BUY
$14.99 - $22.75 $1.06 Million - $1.61 Million
70,720 New
70,720 $1.24 Million

Others Institutions Holding CLDX

# of Institutions
197
Shares Held
68.2M
Call Options Held
208K
Put Options Held
238K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.11B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email